AMGEN INC | Amgen | California | state | 2018 | $198,000 | | training reimbursement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2004 | $85,934 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2005 | $495,039 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2006 | $42,228 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2007 | $60,433 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2009 | $54,069 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2010 | $50,043 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2008 | $55,672 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2011 | $48,189 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2012 | $49,186 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2013 | $48,688 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2014 | $29,980 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2015 | $17,469 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2016 | $17,837 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2017 | $17,711 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2019 | $21,846 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2020 | $21,750 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2021 | $6,481 | | tax credit/rebate |
Alpharma, Inc. | Pfizer | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Alpharma Specialty Pharma, Inc. | Pfizer | North Carolina | state | 2012 | $3,885 | | tax credit/rebate |
Alpharma Inc | Pfizer | West Virginia | state | 2008 | undisclosed | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $677,616 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $1,875,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2016 | $2,250,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2018 | $1,650,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2019 | $2,250,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2021 | $1,950,000 | | tax credit/rebate |
Alnylam Pharmaceuticals | Alnylam Pharmaceuticals | Massachusetts | state | 2014 | $612,930 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | | $50,000 | | grant |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2012 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2011 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2013 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2014 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2015 | $100,000 | | tax credit/rebate |
Allergan Sales, LLC | AbbVie | New Jersey | state | 2011 | $14,906,273 | | grant |
Allergan Sales, LLC | AbbVie | New Jersey | state | 2016 | $58,284,000 | | tax credit/rebate |
Allergan Sales, LLC | AbbVie | New Jersey | state | 2016 | $58,284,000 | | MEGADEAL (Archived) |
Allergan Sales, LLC | AbbVie | North Carolina | state | 2017 | $232,175 | | tax credit/rebate |
Allergan Inc. | AbbVie | Texas | local | 2012 | undisclosed | | grant |
ALLERGAN INC | AbbVie | California | state | 2015 | $325,700 | | training reimbursement |
Alexion Pharmaceuticals, Inc. | AstraZeneca | Connecticut | state | 2016 | $25,000,000 | | tax credit/rebate |
Alexion Pharmaceuticals, Inc | AstraZeneca | Connecticut | state | 2013 | $26,000,000 | | grant/loan hybrid program |
Alexion Pharmaceuticals | AstraZeneca | Connecticut | state | 2012 | $51,000,000 | | tax credit/rebate |
Alexion Pharmaceuticals | AstraZeneca | Rhode Island | state | 2013 | undisclosed | | tax credit/rebate |
Alere, Inc | Abbott Laboratories | Missouri | state | 2017 | $3,220,080 | | tax credit/rebate |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2011 | $16,437 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2012 | $15,630 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2013 | $18,018 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2014 | $13,652 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2015 | $6,697 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2016 | $8,387 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2017 | $7,824 | | property tax abatement |
Aldrich Chemical | Merck KGaA (EMD) | Wisconsin | state | 2003 | $2,426,984 | | tax increment financing |
Alcami Carolinas Corporation | Alcami | North Carolina | state | 2016 | $54,466 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | North Carolina | state | 2017 | $35,605 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | South Carolina | state | 2022 | undisclosed | | grant |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2013 | $350,000 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2012 | $50,000 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $8,249 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2001 | $944,526 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2002 | $95,858 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $5,679,250 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2011 | $54,000 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2012 | $191,566 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2013 | $191,000 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2014 | $63,126 | | enterprise zone |
Albany Molecular Research | Curia Inc. | New York | local | 2009 | $9,218 | | tax credit/rebate; property tax abatement |
Albany Molecular Research | Curia Inc. | New York | local | 2009 | $6,837 | | tax credit/rebate; property tax abatement |
Albany Molecular Research | Curia Inc. | New York | local | 2010 | $8,319 | | tax credit/rebate; property tax abatement |
Albany Molecular Research | Curia Inc. | New York | local | 2008 | $20,029 | | tax credit/rebate; property tax abatement |
Albany Molecular Research | Curia Inc. | New York | local | 2011 | $4,998 | | tax credit/rebate; property tax abatement |
Albany Molecular Research | Curia Inc. | New York | local | 2012 | $1,624 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2005 | $258,802 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2006 | $266,119 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2007 | $275,469 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2009 | $248,601 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2010 | $238,159 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2008 | $237,775 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2011 | $395,043 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2012 | $253,726 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2013 | $166,931 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2014 | $98,411 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2015 | $27,178 | | tax credit/rebate |
Akorn, Inc. | Akorn Inc. | Illinois | state | 2015 | $596,900 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2012 | $5,319 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2014 | $8,340 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2015 | $3,448 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2016 | $22,708 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2018 | $9,300 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2017 | $32,567 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2012 | $96,303 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2013 | $160,000 | | tax credit/rebate |
Aegerion Pharmaceuticals | Amryt Pharma | Massachusetts | state | 2014 | $715,085 | | tax credit/rebate |
Advanced Neuromodulation Systems, Inc. | Abbott Laboratories | Oregon | state | 2006 | $29,872 | | training reimbursement |
Advanced Neuromodulation Systems | Abbott Laboratories | Texas | local | 2006 | undisclosed | | tax credit/rebate |
Actavis, Inc. | AbbVie | Florida | state | 2013 | $690,000 | | grant |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |